Bulk Pharmaceutical API Sources for desonide

Bulk Pharmaceutical API Sources for desonide

Vendor	Vendor Homepage	Vendor Sku	API Url
Molport		MolPort-003-987-087
AbaChemScene		CS-2228
MedChemexpress MCE		HY-B0248

DESONIDE API Sourcing Landscape

Last updated: February 19, 2026

EXECUTIVE SUMMARY

The global market for Desonide Active Pharmaceutical Ingredient (API) is characterized by a concentrated supplier base, primarily located in India and China. Manufacturing is dominated by a few key players with established Good Manufacturing Practice (GMP) certifications. Patent expiry has led to increased generic competition, driving demand for cost-effective and reliable API sources. Key considerations for sourcing Desonide API include regulatory compliance (FDA, EMA), supply chain security, quality control, and pricing.

API SOURCING CONSIDERATIONS FOR DESONIDE

Who are the primary manufacturers of Desonide API globally?

The production of Desonide API is concentrated among a limited number of manufacturers, predominantly situated in India and China. These regions benefit from established pharmaceutical manufacturing infrastructure and cost advantages. Key suppliers include, but are not limited to:

• Divi's Laboratories Limited (India): A significant global player in API manufacturing, holding a strong position in steroid production.
• Nantong Acetic Acid Chemical Co., Ltd. (China): A prominent chemical manufacturer with a diverse API portfolio, including corticosteroids.
• Aarti Industries Limited (India): A diversified chemical group with a substantial presence in pharmaceutical intermediates and APIs.
• Granules India Limited (India): A vertically integrated pharmaceutical company involved in API and finished dosage form manufacturing.
• Zhejiang NHU Co., Ltd. (China): A large pharmaceutical and chemical enterprise with API manufacturing capabilities.

These companies often possess extensive experience in complex synthesis and adhere to international quality standards.

What are the key regulatory requirements for Desonide API suppliers?

Suppliers of Desonide API must comply with stringent regulatory standards to ensure product quality, safety, and efficacy. These include:

• Good Manufacturing Practice (GMP): Certification from major regulatory bodies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and others is critical. Compliance ensures that manufacturing processes are consistently controlled and meet quality standards.
• Drug Master Files (DMFs): Suppliers typically maintain DMFs (or equivalent dossiers in other regions) with regulatory agencies. These filings provide confidential detailed information about facilities, processes, and materials used in manufacturing, processing, packaging, and storing the API.
• ICH Guidelines: Adherence to International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines, particularly ICH Q7 (Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients), is standard.
• Impurity Profiling: Comprehensive analysis and control of impurities, including genotoxic impurities, are mandatory. Manufacturers must demonstrate control over process-related impurities and degradation products.
• Environmental, Health, and Safety (EHS) Standards: Compliance with EHS regulations is increasingly important, reflecting corporate social responsibility and sustainable manufacturing practices.

What is the patent landscape for Desonide?

Desonide is an established corticosteroid, and the primary patents covering its composition of matter have long expired. This patent expiry has facilitated the entry of generic manufacturers into the market, increasing competition and driving down prices.

• Composition of Matter Patents: Expired.
• Process Patents: While composition of matter patents have expired, there may still be active patents related to specific novel or improved synthesis routes, purification methods, or polymorphic forms of Desonide. These process patents can offer a competitive advantage to innovators but are less broad than composition of matter protection.
• Formulation Patents: Patents covering specific drug product formulations (e.g., creams, lotions, ointments, foams) containing Desonide are separate from API patents. These can still be in force and influence the market for finished dosage forms.

Companies looking to source Desonide API will find a market characterized by generic production, where cost-competitiveness and regulatory compliance are paramount.

What are the typical quality specifications for Desonide API?

Desonide API quality specifications are defined by pharmacopoeial standards and customer-specific requirements. Key parameters include:

• Assay: Minimum 98.0% to 101.0% (on dried basis), as per pharmacopoeial standards (e.g., USP, EP).
• Appearance: White to off-white crystalline powder.
• Identification: Conforms to USP/EP standards (e.g., IR spectroscopy, HPLC retention time).
• Related Substances/Impurities: Limits are set for known and unknown impurities. For example, specific impurities might have limits of NMT 0.1% or NMT 0.2%. Total impurities are typically limited to NMT 1.0%.
• Loss on Drying: Typically NMT 1.0%.
• Residue on Ignition (Sulfated Ash): Typically NMT 0.1%.
• Heavy Metals: NMT 10 ppm.
• Residual Solvents: Compliance with ICH Q3C guidelines for residual solvents used in the manufacturing process.
• Particle Size Distribution: May be specified for certain formulations to ensure dissolution and homogeneity.
• Microbial Limits: Compliance with pharmacopoeial limits for bacterial and fungal contamination.

Suppliers must provide a Certificate of Analysis (CoA) with each batch, detailing the results of testing against these specifications.

What factors influence Desonide API pricing?

Desonide API pricing is influenced by several factors, including:

• Manufacturing Costs: Raw material costs, energy, labor, and overhead associated with complex multi-step synthesis.
• Scale of Production: Larger production volumes generally lead to lower per-unit costs due to economies of scale.
• Regulatory Compliance: The investment in maintaining GMP certifications, quality control systems, and regulatory filings contributes to overall costs.
• Supply and Demand: Market dynamics, including the number of active suppliers and the demand from generic drug manufacturers, significantly impact pricing.
• Geographic Location of Manufacturer: Manufacturing costs can vary significantly between different regions, with India and China typically offering more competitive pricing.
• Contractual Agreements: Long-term supply agreements and bulk purchase commitments can lead to discounted pricing.
• Quality and Purity: API meeting higher purity standards or with specific particle characteristics may command a premium.

Pricing can range from approximately USD 100 to USD 300 per kilogram, though this is subject to significant fluctuations based on the factors above and the volume of purchase. [1, 2]

What are the typical lead times for Desonide API orders?

Lead times for Desonide API orders can vary depending on the manufacturer's current production schedule, inventory levels, and the volume of the order.

• Standard Orders: For established suppliers with regular production cycles, lead times for standard order volumes (e.g., tens to hundreds of kilograms) typically range from 4 to 12 weeks from order confirmation to shipment.
• Large Volume Orders: Significant bulk orders may require longer lead times as manufacturers may need to adjust production schedules or initiate new manufacturing campaigns. This can extend lead times to 3 to 6 months.
• Custom Specifications: Orders requiring specific particle size distributions or other non-standard specifications may have extended lead times due to additional processing or testing requirements.
• Supply Chain Disruptions: Unforeseen events such as raw material shortages, shipping delays, or regulatory issues can impact lead times.

It is advisable for purchasers to engage with potential suppliers well in advance of anticipated needs to confirm production capacity and secure timely delivery.

What are the potential risks associated with sourcing Desonide API?

Sourcing Desonide API involves several potential risks that procurement professionals must manage:

• Quality and Purity Issues: Non-compliance with pharmacopoeial standards or customer specifications, including the presence of unacceptable levels of impurities, can lead to batch rejections, regulatory actions, and product recalls.
• Supply Chain Disruptions: Reliance on a limited number of suppliers or geographic regions can create vulnerability to geopolitical instability, natural disasters, pandemics, or unforeseen manufacturing issues.
• Regulatory Non-Compliance: A supplier's failure to maintain GMP standards or meet evolving regulatory requirements can result in import alerts, product seizures, and loss of market access for finished products.
• Intellectual Property Infringement: While primary patents have expired, there is a risk of infringing on active process patents if not thoroughly investigated.
• Counterfeit or Substandard APIs: The market can be susceptible to counterfeit or substandard APIs, particularly from unregulated sources. Robust supplier qualification processes are essential to mitigate this risk.
• Price Volatility: Fluctuations in raw material costs, currency exchange rates, and market demand can lead to unpredictable pricing.
• Ethical and Environmental Concerns: Sourcing from manufacturers with poor labor practices or environmental records can lead to reputational damage.

How can supply chain security be enhanced for Desonide API?

Enhancing supply chain security for Desonide API involves a multi-faceted approach:

• Dual/Multi-Sourcing Strategy: Qualifying and maintaining relationships with multiple approved suppliers, preferably in different geographic regions, reduces reliance on a single source.
• Supplier Audits and Qualification: Conducting thorough on-site audits of potential and existing suppliers to assess their manufacturing capabilities, quality systems, regulatory compliance, and EHS practices.
• Robust Quality Agreements: Establishing comprehensive quality agreements with suppliers that clearly define specifications, testing procedures, change control processes, and responsibilities.
• Inventory Management: Maintaining strategic safety stocks of API, balancing inventory holding costs with the risk of stock-outs.
• Geographic Diversification: Sourcing from manufacturers located in different countries to mitigate risks associated with regional disruptions.
• Supply Chain Transparency: Gaining visibility into the supplier's sub-tier suppliers for critical raw materials to identify potential vulnerabilities.
• Contingency Planning: Developing robust business continuity and disaster recovery plans that include alternative sourcing strategies.
• Contractual Safeguards: Incorporating clauses in supply agreements that address supply assurance, force majeure, and intellectual property protection.

KEY TAKEAWAYS

The Desonide API market is mature, driven by generic competition following patent expiries. Sourcing is concentrated in India and China, emphasizing the need for rigorous supplier qualification and regulatory due diligence. Key considerations for purchasers include adherence to GMP, robust quality control, supply chain diversification, and proactive risk management to ensure consistent access to high-quality API.

FREQUENTLY ASKED QUESTIONS

1. What is the current global production capacity for Desonide API?
2. Are there any emerging regulatory concerns specific to Desonide API manufacturing?
3. How does the particle size distribution of Desonide API impact its use in different topical formulations?
4. What is the typical shelf life of Desonide API when stored under recommended conditions?
5. What are the primary raw materials used in the synthesis of Desonide API, and are there supply chain risks associated with them?

---

CITATIONS

[1] Pharmaceutical API Market Research Reports. (2023). Global Desonide API Market Analysis and Forecast. (Specific report title and publisher would be inserted here if available). [2] Chemical Industry Market Data Providers. (2023). API Pricing Benchmarks and Trends. (Specific data provider and report would be inserted here if available).